Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment Emily M. SchehleinAlan L. Robin Leading Article 27 May 2019 Pages: 1031 - 1036
Recent Developments in LRRK2-Targeted Therapy for Parkinson’s Disease Ye ZhaoNicolas Dzamko Leading Article 03 June 2019 Pages: 1037 - 1051
A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy Sherman PicardoCynthia H. Seow Review Article 10 June 2019 Pages: 1053 - 1063
Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis Hennie G. RatermanIrene E. M. BultinkWillem F. Lems Review Article 14 June 2019 Pages: 1065 - 1087
Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes Rozana RamliMonika ReddyNick Oliver Review Article 12 June 2019 Pages: 1089 - 1101
Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments Kazuki SawamotoMolly StapletonShunji Tomatsu Review Article 17 June 2019 Pages: 1103 - 1134
Dapagliflozin: A Review in Type 2 Diabetes Sohita Dhillon Adis Drug Evaluation Open access 25 June 2019 Pages: 1135 - 1146
Damoctocog Alfa Pegol: A Review in Haemophilia A Julia PaikEmma D. Deeks Adis Drug Evaluation Open access 19 June 2019 Pages: 1147 - 1156
Remogliflozin Etabonate: First Global Approval Anthony Markham AdisInsight Report 14 June 2019 Pages: 1157 - 1161